Therefore, our findings have demonstrated that EIF3H is a promising deubiquitinating enzyme of OGT and participated in the progression of HCC through ferroptosis, which provides new insights into clinical diagnosis and drug target exploration of HCC. This evidence concerns the gene OGT and hepatocellular carcinoma.